Abstract
In its first significant judgment on claim construction in over 25 years, Ireland's High Court approved the principles laid down by the English House of Lords in Kirin-Amgen, holding that Warner-Lambert's ‘Lipitor’ patent is not limited to a racemic mixture and refusing Ranbaxy a declaration of non-infringement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Intellectual Property Law & Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
